3 Funds To Gain From Antiviral Drug Therapies

We expect these funds to outperform peers in the future. Remember, the goal of the Zacks Mutual Fund Rank is to guide investors to identify potential winners and losers. Unlike most of the fund-rating systems, the Zacks Mutual Fund Rank is not just focused on past performance but also on the likely future success of the fund.

The question here is why should investors consider mutual funds? Reduced transaction costs and diversification of portfolio without several commission charges that are associated with stock purchases are primarily why one should be parking money in mutual funds.

Fidelity Select Biotechnology Portfolio (FBIOX - Free Report) aims for capital appreciation. The fund invests the majority of its assets in securities of companies that research, develop, manufacture, and distribute various biotechnological products and services. FBIOX is a non-diversified fund. AbbVie Inc, which is a major player in the anti-viral drug therapy market, is among FBIOX’s top holdings. FBIOX carries a Zacks Mutual Fund Rank #1.

This Zacks Sector – Health has a history of positive total returns for more than 10 years.

FBIOX has an annual expense ratio of 0.72%, which is below the category average of 1.24%. It has returned 4.6% over the past three years. The fund has no minimum initial investment.

Hartford Healthcare HLS Fund Class IA (HIAHX - Free Report) aims for long-term capital growth. The fund invests the majority of its assets in securities of healthcare-related companies. The fund invests across companies of all market capitalizations. Bristol-Myers Squibb Company and Medtronic PLC are among the fund’s top holdings. These companies have operations in the area of antiviral drug therapy. HIAHX carries a Zacks Mutual Fund Rank #2.

This Zacks Sector – Health has a history of positive total returns for more than 10 years.

HIAHX has an annual expense ratio of 0.89%, which is below the category average of 1.24%. It has returned 6.9% over the past three years. The fund has no minimum initial investment.

View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.